openPR Logo
Press release

Peptide Hormones Market & Pipeline Insight 2015

06-29-2017 08:35 AM CET | Health & Medicine

Press release from: Kuick Resarch

Human body consists of myriad of chemicals required for signaling, providing nutrients, proper growth and development. Hormones are one such chemical present in the body that plays a very important role in maintaining homeostasis. They are secreted from endocrine glands which are also known as duct less gland because hormones are directly secreted into the blood stream. Moreover, diversity could be observed in their molecular structure, chemical nature, functionality, site of secretion and action. Among hormones, peptide hormones form an important category consisting of short amino acid chains of varying sizes. They are secreted in miniscule quantities but their effect is profound on target tissue which may be distant to the site of secretion. Despite this fact, they are indispensible in nature and investigators are trying to increase understanding about their action mechanism to come forth with suitable therapeutics.

Diseases due to deficiency of peptide hormone have been observed by investigators and cure for some of them has been marketed across the globe. Investigators have found more than 50 types of hormones in body belonging to different classes having characteristic biochemical and biophysical properties. In this way, they offer huge commercialization potential but all of them don’t have significant therapeutic benefits as compared to peptide hormones. They are customizable in nature due which they could be modulated according to the receptor molecules. As a result, their specificity increases several folds providing higher safety profile along with minimized side effects. Moreover, increased potency is among other benefits due to which lesser dosage is required for achieving higher therapeutic benefits. These favorable feature makes them a suitable candidate having significant therapeutic and commercialization potential in several disease categories.

Download Report:

https://www.kuickresearch.com/report-Peptide-Hormones-Market-&-Pipeline-Insight-2015.php

Pharmaceutical companies have recognized the commercialization and therapeutic potential of peptide hormones for treating various diseases. As a result, they are investing more funds in research and development segment to develop novel therapeutics to fulfill high unmet medical necessities. Several peptide hormone drug development programs have been instigated by pharmaceutical companies which would help in generating significant revenues. Their administrations in several hormonal imbalances have shown proven safety and efficacy profiles leading to higher acceptance among patients. In past few years, new mechanisms have been deciphered by investigators that will offer more options to patients suffering from various peptide hormone disorders. It is expected that investigators would introduce innovative therapeutics in market due to increased funding in research and development segment.

Several years of knowledge has been gathered by investigators due to which market introduction of new peptide hormones is expected to take place in coming years. Progress has been made in improvement of peptide design and candidate molecule screening are undergoing through different phases of clinical trials. These innovative peptide hormones are expected to enter in global market in coming years for various disease categories. Due to significant therapeutic efficacy they are expected to compete effectively and erode profit of other therapeutics. Moreover, newer instruments are expected to be introduced for providing better control over quantity and quality of peptide hormones. Besides this their manufacturing capabilities are expected to increase several folds and introduction of superior technology will further allow the pharmaceutical manufacturers to achieve higher production at competitive pricing. With all these positive development, the future of peptide hormones seems to be optimistic.

“Peptide Hormones Market & Pipeline Insight 2015” Report Highlight:

* Global Peptide Hormone Market Overview
* Peptide Hormones Clinical Pipeline by Company, Indication & Phase
* Marketed Peptide Hormones by Company & Indication
* Peptide Hormones Clinical Pipeline: 47 Drugs
* Majority Peptide Hormone in Phase-II Trials: 15 Drugs
* Marketed Peptide Hormones: 24 Drugs
* Global Peptide Hormone Market Future Prospects

For Report Sample Contact: neeraj@kuickresearch.com or

visit: https://www.kuickresearch.com

Recent Publications:

* Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
* Global CAR T Cell Therapy Market & Clinical Trials Insight 2022
* Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023
* Global Microcapsules Drug Delivery Market Opportunity Outlook 2022
* Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022
* Global Cancer Antibody Drug Conjugates Market & Pipeline Insight 2022
* Global B Cell Lymphoma Market & Clinical Pipeline Insight 2022

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Hormones Market & Pipeline Insight 2015 here

News-ID: 601056 • Views: 147

More Releases from Kuick Resarch

Global Cell Therapy Market To Surpass US$ 400 Billion In Opportunity By 2027 Wit …
"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Cell Therapy Trials For COVID-19: 10 Cell Therapies • Global COVID-19 Cell Therapy Clinical Trials By Phase & Company • COVID-19 Impact Analysis on Global market &
Global Cancer Immunotherapy Market Offers US$ 200 Billion Opportunity With 2300 …
"Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Immunotherapy Market Opportunity: > US$ 200 Billion • Cancer Immunotherapy Clinical Trials: > 2300 Drugs In Trials • Commercially Available Cancer Immunotherapies: > 120 • Cancer Vaccines Market Opportunity: > US$ 20 Billion • Cancer Monoclonal Antibodies Market Opportunity: > US$ 90 Billion • Marketed Cancer Monoclonal Antibodies': > 70 mAbs • Sales, Market Opportunity, Dosage & Price Data: 300 Graphs/Charts • Clinical Trials Insight By Phase,
Global Cell Therapy Market, Therapy Price, Dosage Clinical Trials 2027
"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Cell Therapy Trials For COVID-19: 10 Cell Therapies • Global COVID-19 Cell Therapy Clinical Trials By Phase & Company • COVID-19 Impact Analysis on Global market &
Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027
"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Insight: * Market Opportunity: >USD 40 Billion * Clinical Trial Insight: > 1000 Cell Therapies * COVID-19 Impact Analysis on Global Cell Therapy Market * Cell Therapies For COVID-19: > 10 Cell Therapies * Marketed Cell Therapies: 25 Cell Therapies Download Report: https://www.kuickresearch.com/report-global-cell-therapy-market,-therapy-price,-dosage-and-clinical-trials-insight-2027.php Table of Contents 1. Overview of Cell Therapy 1.1 Introduction to Cell Therapy 1.2 History & Evolution of

All 5 Releases


More Releases for Hormone

Peptide Hormone Global Industry Report - History, Present and Future 2025
The global market size of Peptide Hormone is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
Hormone Replacement Therapy Market Segments And Key Trends 2018-2028
Top Five Companies Account for 35% Share of the Overall Hormone Replacement Therapy Market The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players. Top five companies involved in the hormone replacement therapy formulations account for a significant share of the overall hormone replacement therapy market. Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and
Follicle Stimulating Hormone Market to Reap Excessive Revenues by 2023 ...
Worldwide Market Reports added Latest Research Report titled “Global and Chinese Follicle Stimulating Hormone Industry, 2018 Market Research Report” to its Large Report database. The 'Global and Chinese Follicle Stimulating Hormone Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Follicle Stimulating Hormone industry with a focus on the Chinese market. The report provides key statistics on the market status of the
Global Human Growth Hormone Market 2017 Industry Research Report
Qyresearchreports include new market research report "Global Human Growth Hormone Market 2017 Industry Research Report" to its huge collection of research reports. This given report on the global Human Growth Hormone market, is a result of a research conducted by a group of market research analysis experts with an aim to act as a reliable business material for stake holders. The report offers information on the current market scenario and the
Follicle Stimulating Hormone Market
"This report studies the follicle stimulating hormone market. Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU." Scope of the Report: This report focuses on the Follicle Stimulating Hormone in United States market,
Industrial Report: Global Hormone Agonists Market
Marketresearchreports.biz has added a new research report on the "Hormone Agonists-Pipeline Insights, 2017" to its collection. DelveInsights, Hormone Agonists-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Hormone Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other